✦ LIBER ✦

The clinical, cardiac, renal, arterial and neurohormonal effects of omapatrilat, a vasopeptidase inhibitor, in patients with chronic heart failure

✍ Scribed by Dougal R McClean; Hamid Ikram; Amanda H Garlick; A.Mark Richards; M.Gary Nicholls; Ian G Crozier

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiac and renal effects of omapatrilat

✍ Zaid A. Abassi; Samar Zeid; Ali Yahia; Joseph Winaver; Aaron Hoffman 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 34 KB

Comparison of the effects of omapatrilat

✍ Tej Sheth; Tom Parker; Alan Block; Christian Hall; Albert Adam; Mark A Pfeffer; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Comparison of vasopeptidase inhibitor, o

✍ Jean L Rouleau; Marc A Pfeffer; Duncan J Stewart; Debra Isaac; Francois Sestier; 📂 Article 📅 2000 🏛 The Lancet 🌐 English ⚖ 102 KB

Effects of a new angiotensin-converting

✍ T. Kinugawa; M. Kato; M. Mori; A. Endo; T. Kato; T. Hamada; N. Noguchi; H. Omoda 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 301 KB

Antiinflammatory Effects of Cardiac Resy

✍ GEORGE N. THEODORAKIS; PANAGIOTA FLEVARI; CHRISTOS KROUPIS; STAMATIS ADAMOPOULOS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Renal Effects of Conivaptan, Furosemide,

✍ Steven R. Goldsmith; David T. Gilbertson; Shari A. Mackedanz; Suzanne K. Swan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 197 KB